JOHNSON CARLTON M 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Aug 29, 2017
Insider Transaction Report
Form 4
JOHNSON CARLTON M
Director
Transactions
- Other
Stock Option (right to buy)
2017-08-25−20,024→ 254,189 totalExercise: $9.17Exp: 2025-05-11→ Common Stock (20,024 underlying) - Other
Stock Option (right to buy)
2017-08-25−14,934→ 239,255 totalExercise: $3.50Exp: 2026-06-02→ Common Stock (14,934 underlying)
Footnotes (3)
- [F1]Pursuant to the settlement terms of a derivative lawsuit approved by Vice Chancellor Laster by Order dated July 27, 2017 (the "Settlement Date"), Mr. Johnson has agreed to an annual compensation cap for a period of two years from the Settlement Date. Although not required, on August 25, 2017, Mr. Johnson voluntarily surrendered for cancelation and for no consideration, 20,024 options (originally granted on May 11, 2015) and 14,934 options (originally granted on June 2, 2016), which reduced his total annual compensation for fiscal years 2016 and 2017 to below the agreed upon cap.
- [F2]The underlying option grant provided for vesting in eight (8) equal quarterly installments over a two (2) year period beginning August 11, 2015 and each quarter thereafter until fully-vested.
- [F3]The underlying option grant provided for vesting in eight (8) equal quarterly installments over a two (2) year period beginning September 2, 2016 and each quarter thereafter until fully-vested.